Please login to the form below

Not currently logged in
Email:
Password:

healthcare providers

This page shows the latest healthcare providers news and features for those working in and with pharma, biotech and healthcare.

Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions

Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions

On Sunday, California’s state epidemiologist Dr Erica Pan issued a statement with recommendations for healthcare providers to pause vaccination from the lot in question – no. ... According to the statement, over 330, 000 doses from this lot have been

Latest news

  • Accord Healthcare’s COVID-19 agility praised at PMEA 2020 Accord Healthcare’s COVID-19 agility praised at PMEA 2020

    pandemic to continue to supply, support and engage with healthcare professionals and patients. ... Accord's initiative recognised that a vast number of healthcare providers, intensive care units (ICU) and patients were relying on the company to provide

  • Healthineers’ COVID-19 antibody test launches in EU Healthineers’ COVID-19 antibody test launches in EU

    19. “Healthcare providers can feel confident that our test will help them determine whether a patient's immune system is producing the right antibodies to stop or prevent COVID-19 infection,” ... For each test, the researchers calculated the

  • Novacyt launches diagnostic test to differentiate between COVID-19 and flu Novacyt launches diagnostic test to differentiate between COVID-19 and flu

    The test panel is a key addition to our COVID-19 product portfolio to support healthcare providers as we approach flu season in the Northern hemisphere,” he added.

  • Speed kills Speed kills

    Throwing all caution to the wind as many hospitals and healthcare providers competed with each other, the rush to procure equipment without properly understanding who these medical supply vendors were led ... Rohit Khanna is the Managing Director of

  • Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer Pfizer’s Xalkori follow-up Lorbrena hits the mark in first-line lung cancer

    other healthcare providers, as well as engage with global regulatory authorities to potentially provide this third-generation ALK-inhibitor to  people with previously untreated metastatic non-small cell lung cancer,” he

More from news
Approximately 0 fully matching, plus 321 partially matching documents found.

Latest Intelligence

  • Rebranding in an evolving world Rebranding in an evolving world

    Simultaneously, we are consistently searching for products that fit our brand and portfolio so that we can continue to expand and provide clear value to patients and healthcare providers. ... Overall, as a company and as a team of 550+ staff, our goals

  • Digitising healthcare Digitising healthcare

    Conclusion. Introducing further digitisation into healthcare clearly has great benefits, and by choosing the correct IoT providers the challenges can be mitigated. ... By reducing the myths surrounding patient data and ensuring that connected devices are

  • Why digital is the solution to the healthcare crisis Why digital is the solution to the healthcare crisis

    That can’t be blamed solely on the healthcare providers; prior to the pandemic, consumers were reluctant to interact with their healthcare providers online fearing a lack of privacy, but with ... Google, for example, provides a chatbot that healthcare

  • COVID-19 – a catalyst for technology adoption in clinical trials COVID-19 – a catalyst for technology adoption in clinical trials

    An industry in crisis. As COVID-19 struck and countries went into lockdown, patient visits to healthcare providers dropped dramatically for two main reasons. ... t go away quickly and that healthcare systems will have to work in this ‘new normal’ for

  • Every superhero has an origin story – what’s yours? Every superhero has an origin story – what’s yours?

    Currently, much of this information is not readily available for healthcare providers to consider. ... Integrating pharmacokinetic and pharmacodynamic information into messaging can help healthcare providers move beyond representative clinical trial

More from intelligence
Approximately 0 fully matching, plus 80 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 62 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics